(April, 2017) Read our DI Newsletter (PDF) for updates on:
(December, 2016) The DARTNet Institute is now participating in a new partnership to support research combining the use of an individual's genetic makeup with that of a unique clinical decision support system to help guide medication choices in primary care settings. DARTNet will capture data for a study from patient medical records and collect patient-reported outcomes through questionnaires.
The partnership includes the American College of Clinical Pharmacy Research Institute and Tabula Rasa HealthCare (TRHC), which provides health care organizations with patient-specific, data-driven technology to optimize medication choices to improve patient outcomes, reduce hospitalizations, lower health care costs, and manage risk. questionnaires.
"DARTNet will provide the ability to use embedded data transfer systems from electronic health records to present detailed patient information to Tabula Rasa HealthCare and back to the treating clinicians - both clinical pharmacists and medical clinicians. DARTNet is excited about working with the ACCP PBRN and Tabula Rasa HealthCare to create a system that will allow other practices to consider this approach to medication prescribing," said Dr. Wilson Pace, Chief Medical Officer for the DARTNet Institute.
Read more about the project (PDF).
(November, 2016, Updated February, 2017) A study from DI and the CER2 (Comparative Effectiveness Research through Collaborative Electronic Reporting) group, "Diagnosis and Medication Treatment of Pediatric Hypertension: A Retrospective Cohort Study" by Kaelber and colleagues, was published in Pediatrics. A commentary (Hill KD and Li JS. "Childhood Hypertension: An Underappreciated Epidemic?") was also published.
The Philadelphia Inquirer published an article about the findings.
The AAP News Research Update featured the story as well.